Lentiviral vectors and cardiovascular diseases: A genetic tool for manipulating cardiomyocyte differentiation and function

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Engineered recombinant viral vectors are a powerful tool for vehiculating genetic information into mammalian cells. Because of their ability to infect both dividing and non-dividing cells with high efficiency, lentiviral vectors have gained particular interest for basic research and preclinical studies in the cardiovascular field. We review here the major applications for lentiviral-vector technology in the cardiovascular field: we will discuss their use in trailing gene expression during the induction of differentiation, in protocols for the isolation of cardiac cells and in the tracking of cardiac cells after transplantation in vivo; we will also describe lentivirally-mediated gene delivery uses, such as the induction of a phenotype of interest in a target cell or the treatment of cardiovascular diseases. In addition, a section of the review will be dedicated to reprogramming approaches, focusing attention on the generation of pluripotent stem cells and on transdifferentiation, two emerging strategies for the production of cardiac myocytes from human cells and for the investigation of human diseases. Finally, in order to give a perspective on their future clinical use we will critically discuss advantages and disadvantages of lentivirus-based strategies for the treatment of cardiovascular diseases.

Original languageEnglish
Pages (from-to)642-648
Number of pages7
JournalGene Therapy
Volume19
Issue number6
DOIs
Publication statusPublished - Jun 2012

Fingerprint

Cardiac Myocytes
Cardiovascular Diseases
Cell Transdifferentiation
Cell Tracking
Lentivirus
Pluripotent Stem Cells
Cell Transplantation
Heart Transplantation
Technology
Phenotype
Gene Expression
Therapeutics
Research
Genes

Keywords

  • cardiomyocytes
  • cell tracking
  • heart
  • iPS cells
  • lentiviral vectors
  • reprogramming strategies

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

@article{d8c894755cbb47e2a4c52cfc3456b2f1,
title = "Lentiviral vectors and cardiovascular diseases: A genetic tool for manipulating cardiomyocyte differentiation and function",
abstract = "Engineered recombinant viral vectors are a powerful tool for vehiculating genetic information into mammalian cells. Because of their ability to infect both dividing and non-dividing cells with high efficiency, lentiviral vectors have gained particular interest for basic research and preclinical studies in the cardiovascular field. We review here the major applications for lentiviral-vector technology in the cardiovascular field: we will discuss their use in trailing gene expression during the induction of differentiation, in protocols for the isolation of cardiac cells and in the tracking of cardiac cells after transplantation in vivo; we will also describe lentivirally-mediated gene delivery uses, such as the induction of a phenotype of interest in a target cell or the treatment of cardiovascular diseases. In addition, a section of the review will be dedicated to reprogramming approaches, focusing attention on the generation of pluripotent stem cells and on transdifferentiation, two emerging strategies for the production of cardiac myocytes from human cells and for the investigation of human diseases. Finally, in order to give a perspective on their future clinical use we will critically discuss advantages and disadvantages of lentivirus-based strategies for the treatment of cardiovascular diseases.",
keywords = "cardiomyocytes, cell tracking, heart, iPS cells, lentiviral vectors, reprogramming strategies",
author = "{Di Pasquale}, E. and Latronico, {M. V G} and Jotti, {G. S.} and G. Condorelli",
year = "2012",
month = "6",
doi = "10.1038/gt.2012.19",
language = "English",
volume = "19",
pages = "642--648",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Lentiviral vectors and cardiovascular diseases

T2 - A genetic tool for manipulating cardiomyocyte differentiation and function

AU - Di Pasquale, E.

AU - Latronico, M. V G

AU - Jotti, G. S.

AU - Condorelli, G.

PY - 2012/6

Y1 - 2012/6

N2 - Engineered recombinant viral vectors are a powerful tool for vehiculating genetic information into mammalian cells. Because of their ability to infect both dividing and non-dividing cells with high efficiency, lentiviral vectors have gained particular interest for basic research and preclinical studies in the cardiovascular field. We review here the major applications for lentiviral-vector technology in the cardiovascular field: we will discuss their use in trailing gene expression during the induction of differentiation, in protocols for the isolation of cardiac cells and in the tracking of cardiac cells after transplantation in vivo; we will also describe lentivirally-mediated gene delivery uses, such as the induction of a phenotype of interest in a target cell or the treatment of cardiovascular diseases. In addition, a section of the review will be dedicated to reprogramming approaches, focusing attention on the generation of pluripotent stem cells and on transdifferentiation, two emerging strategies for the production of cardiac myocytes from human cells and for the investigation of human diseases. Finally, in order to give a perspective on their future clinical use we will critically discuss advantages and disadvantages of lentivirus-based strategies for the treatment of cardiovascular diseases.

AB - Engineered recombinant viral vectors are a powerful tool for vehiculating genetic information into mammalian cells. Because of their ability to infect both dividing and non-dividing cells with high efficiency, lentiviral vectors have gained particular interest for basic research and preclinical studies in the cardiovascular field. We review here the major applications for lentiviral-vector technology in the cardiovascular field: we will discuss their use in trailing gene expression during the induction of differentiation, in protocols for the isolation of cardiac cells and in the tracking of cardiac cells after transplantation in vivo; we will also describe lentivirally-mediated gene delivery uses, such as the induction of a phenotype of interest in a target cell or the treatment of cardiovascular diseases. In addition, a section of the review will be dedicated to reprogramming approaches, focusing attention on the generation of pluripotent stem cells and on transdifferentiation, two emerging strategies for the production of cardiac myocytes from human cells and for the investigation of human diseases. Finally, in order to give a perspective on their future clinical use we will critically discuss advantages and disadvantages of lentivirus-based strategies for the treatment of cardiovascular diseases.

KW - cardiomyocytes

KW - cell tracking

KW - heart

KW - iPS cells

KW - lentiviral vectors

KW - reprogramming strategies

UR - http://www.scopus.com/inward/record.url?scp=84862004322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862004322&partnerID=8YFLogxK

U2 - 10.1038/gt.2012.19

DO - 10.1038/gt.2012.19

M3 - Article

C2 - 22378345

AN - SCOPUS:84862004322

VL - 19

SP - 642

EP - 648

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 6

ER -